0 Commentaires
0 Parts
122 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Connectez-vous pour aimer, partager et commenter!
-
Dengue Vaccines Market Size Projected to Reach USD 1,632.11 Million by 2032According to a new report published by Introspective Market Research, Dengue Vaccines Market by Type, Treatment, Route of Administration, and End-Users, The Global Dengue Vaccines Market Size Was Valued at USD 598.10 Million in 2023 and is Projected to Reach USD 1,632.11 Million by 2032, Growing at a CAGR of 11.80%. A dengue vaccine is a biological preparation designed to provide acquired...0 Commentaires 0 Parts 369 Vue 0 Aperçu
-
Digital Immunization Records, Precision Dosing, and Expanding Vaccination Horizons Driving Italy Poultry Vaccines Market ProjectionsFuture vaccination strategies in Italy will likely incorporate digital health monitoring tools that track immunization records, flock status, and disease susceptibility across farms. These technologies will support precision dosing, predictive analytics, and easier regulatory compliance. This emerging direction aligns with expected outcomes within Italy Poultry Vaccines Market Projections as...0 Commentaires 0 Parts 609 Vue 0 Aperçu
-
Global Vaccines Market to Reach USD 113.70 Billion by 2033, Growing at 7.07% CAGRThe global vaccines market size was valued at USD 67.58 billion in 2024 and is projected to grow from USD 65.83 billion in 2025 to USD 113.70 billion by 2033, exhibiting a CAGR of 7.07% during the forecast period (2025-2033). Market Overview The global Vaccines market is witnessing swift transformation driven by new consumer behaviors, increased funding, and...0 Commentaires 0 Parts 787 Vue 0 Aperçu
-
Nasal Vaccines Market Size Projected to Reach USD 876.2 Million by 2032The global Nasal Vaccines Market comprises prophylactic products designed for administration through the nasal route, typically as a spray or mist, to induce immunity against infectious diseases. These vaccines are gaining significant traction as a non-invasive alternative to traditional injectable vaccines. By targeting the mucosal lining of the respiratory tract—the primary entry point...0 Commentaires 0 Parts 458 Vue 0 Aperçu
-
TCV Vaccines Market Size Projected to Reach USD 1,067.5 Million by 2032The TCV Vaccine Market represents a critical segment of the global immunization landscape, focusing on the prevention of typhoid fever caused by the bacterium Salmonella Typhi. Unlike traditional Vi polysaccharide vaccines, TCVs are conjugated to a protein carrier, which triggers a more robust and long-lasting immune response, even in infants as young as six months. This technological...0 Commentaires 0 Parts 430 Vue 0 Aperçu